Health Affairs, 24, no. 3 (2005): 596-597 doi: 10.1377/hlthaff.24.3.596 © 2005 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mahmoud, A. Search for Related Content PubMed PubMed Citation Articles by Mahmoud, A. Related Collections Vaccines

Foreword

The Vaccine Enterprise: Time To Act

Vaccines have led to some of the greatest achievements in public health and are among the most cost-effective health interventions. Mass immunization programs have resulted in the global eradication of smallpox and the elimination of polio from the Western Hemisphere, Europe, and much of Asia, while vaccines for diseases like measles, pertussis, and diphtheria have dramatically reduced childhood mortality worldwide. In the United States, record-high levels of immunization have been achieved for young children, and in March 2005 the Centers for Disease Control and Prevention (CDC) announced that rubella, or German measles, is no longer a health threat in the . . . [Full Text of this Article]

                      What's this?